BeStock  
Stocks › Biotechnology › VOR

Vor Biopharma VOR

US equityMarket cap rank #3164Biotechnology
$18.78 +$0.47 (+2.57%)
Pre-market · Oct 8, 7:00 am ET · After hours $18.78 0.00%
Open$18.09
Prev close$18.31
Day range$17.86 – $18.90
Volume563.1K
Market cap$1.11B
P/E (TTM)1.6
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$47.85M+82.6% YoY
Net profit-$62.81M+96.0% YoY
Diluted EPS-$1.16+99.5% YoY
Free cash flow-$25.50M+27.8% YoY
Operating cash flow-$25.38M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-27.6MSep '24$-30.7MDec '24$-32.5MMar '25$-1.6BJun '25$-812.7MSep '25$1.7BDec '25$-219.6MMar '26$-62.8MJun '26

Diluted EPS by quarter

-8.05Sep '24-8.78Dec '24-5.21Mar '25-251.24Jun '25-121.63Sep '2544.50Dec '25-5.11Mar '26-1.16Jun '26

Free cash flow by quarter

$-23.3MSep '24$-24.1MDec '24$-31.3MMar '25$-35.3MJun '25$-53.9MSep '25$-23.1MDec '25$-38.3MMar '26$-25.5MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on assets182.9%
Current ratio19.15
Liabilities / assets141.6%
Cash & investments$466.13M
Total debt$2.54M
Net cash (debt)$463.59M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $47.85M $35.16M $371.64M $35.96M $28.11M
Selling and Admin Expenses $21.93M $17.57M $50.11M $16.77M $13.97M
-General & Admin Expense $21.93M $17.57M $50.11M $16.77M $13.97M
Research & Development $25.92M $17.60M $321.53M $19.19M $14.14M
Operating Profit -$47.85M -$35.16M -$371.64M -$35.96M -$28.11M
Net Non-Operating Interest Income (Expense) $4.34M $3.94M $5.87M $2.80M $1.73M
Non-Operating Interest Income $4.34M $3.94M $5.87M $2.80M $1.73M
Other Income (Expense) -$19.30M -$188.36M -$330.21M $1.76B -$786.31M
Gain on Sale of Security -$19.30M -$188.36M -$334.36M $1.76B -$790.46M
Pretax Profit -$62.81M -$219.59M -$695.98M $1.72B -$812.68M
Net Profit -$62.81M -$219.59M -$695.98M $1.72B -$812.68M
Profit from Continuing Operations -$62.81M -$219.59M -$695.98M $1.72B -$812.68M
Net Income to Parent Company -$62.81M -$219.59M -$695.98M $1.72B -$812.68M
Net Income to Common Stockholders -$62.81M -$219.59M -$695.98M $1.72B -$812.68M
Basic EPS -$1.16 -$5.11 -$70.50 $44.50 -$121.63
Diluted EPS -$1.16 -$5.11 -$70.50 $44.50 -$121.63
Other Non-Operating Income (Expenses) – – $4.15M $2,000.00 $4.15M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $481.05M $506.75M $464.13M $464.13M $176.24M
Total Current Assets $475.11M $500.78M $458.11M $458.11M $172.49M
Cash and Cash Equivalents & Short-Term Investments $466.13M $491.53M $455.21M $455.21M $170.46M
-Cash and Cash Equivalents $107.86M $169.87M $396.49M $396.49M $160.46M
-Short Term Investments $358.27M $321.65M $58.72M $58.72M $10.00M
Prepaid Assets $5.88M $6.39M $1.15M $1.15M $747,000.00
Other Current Assets $3.10M $2.86M $1.75M $1.75M $1.28M
Total Non-Current Assets $5.95M $5.97M $6.02M $6.02M $3.75M
Net PPE $3.37M $3.39M $3.47M $3.47M $3.31M
-Gross PPE $3.46M $3.45M $3.49M $3.49M $3.32M
-Accumulated Depreciation -$90,000.00 -$53,000.00 -$25,000.00 -$25,000.00 -$1,000.00
Other Non-Current Assets $2.58M $2.58M $2.55M $2.55M $437,000.00
Total Liabilities $681.25M $657.17M $628.44M $628.44M $2.40B
Total Current Liabilities $24.81M $16.08M $25.17M $25.17M $18.84M
Payables $4.00M $1.04M $5.13M $5.13M $885,000.00
-Accounts Payable $4.00M $1.04M $5.13M $5.13M $885,000.00
Current Accrued Expenses $15.76M $11.80M $16.14M $16.14M $14.48M
Short-Term Debt and Capital Lease Obligation $335,000.00 $307,000.00 $280,000.00 $280,000.00 $252,000.00
-Current Capital Lease Obligation $335,000.00 $307,000.00 $280,000.00 $280,000.00 $252,000.00
Total Non-Current Liabilities $656.44M $641.09M $603.27M $603.27M $2.38B
Long Term Debt and Capital Lease Obligation $2.54M $2.63M $2.72M $2.72M $2.81M
-Long Term Capital Lease Obligation $2.54M $2.63M $2.72M $2.72M $2.81M
Derivative Product Liabilities $653.89M $638.46M $600.55M $600.55M $2.38B
Total Equity -$200.20M -$150.42M -$164.31M -$164.31M -$2.23B
Stockholders' Equity -$200.20M -$150.42M -$164.31M -$164.31M -$2.23B
Capital Stock $19,000.00 $19,000.00 $18,000.00 $18,000.00 $15,000.00
-Common Stock $19,000.00 $19,000.00 $18,000.00 $18,000.00 $15,000.00
-Preferred Stock $0.00 – $0.00 $0.00 $0.00
Additional Paid-In Capital $1.24B $1.22B $988.60M $988.60M $650.32M
Retained Earnings -$1.44B -$1.37B -$1.15B -$1.15B -$2.88B
Gains/Losses Not Affecting Retained Earnings -$922,000.00 -$706,000.00 $41,000.00 $41,000.00 $12,000.00
Other Current Liabilities – $698,000.00 $554,000.00 $554,000.00 $193,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$25.38M -$38.25M -$142.71M -$22.80M -$53.66M
Net cash flow from continuing operations -$25.38M -$38.25M -$142.71M -$22.80M -$53.66M
Net Income from Continuing Operations -$62.81M -$219.59M -$695.98M $1.72B -$812.68M
Depreciation & Depletion & Amortization $36,000.00 $28,000.00 $2.89M $23,000.00 $2,000.00
Other Non-Cash Items -$188.25M $188.47M $518.03M $334.50M -$44.55M
Change in Working Capital $9.01M -$15.54M $10.21M $3.16M $5.06M
-Change in Prepaid Assets $278,000.00 -$6.36M $1.68M -$873,000.00 -$75,000.00
-Change in Payables and Accrued Expense $8.80M -$9.10M $10.93M $6.21M $5.00M
-Change in Other Current Assets -$7,000.00 -$20,000.00 $0.00 -$2.11M $151,000.00
-Change in Other Current Liabilities -$62,000.00 -$61,000.00 -$2.41M -$59,000.00 -$20,000.00
Net cash flow from investing -$36.53M -$263.24M -$48.80M -$48.97M -$244,000.00
Net Cash Flow from Continuing Investing Activities -$36.53M -$263.24M -$48.80M -$48.97M -$244,000.00
Net PPE Purchase and Sale -$120,000.00 -$48,000.00 -$142,000.00 -$314,000.00 -$244,000.00
Net Investment Purchase and Sale -$36.41M -$263.19M -$48.66M -$48.66M $0.00
Financing Cash Flow -$106,000.00 $74.87M $503.81M $307.80M $21.55M
Net Cash Flow from Continuing Financing Activities -$106,000.00 $74.87M $503.81M $307.80M $21.55M
Net Common Stock Issuance $0.00 $75.00M $328.21M $307.95M $20.26M
Proceeds from Stock Option Exercised $1,000.00 -$2,000.00 $176.93M -$19,000.00 $1.94M
Net Other Financing Charges -$107,000.00 -$127,000.00 -$1.33M -$131,000.00 -$643,000.00
Ending Cash Balance $108.02M $170.04M $396.65M $396.65M $160.63M
Net Change in Cash -$62.02M -$226.61M $312.29M $236.02M -$32.36M
Beginning Cash Balance $170.04M $396.65M $84.36M $160.63M $192.99M
Free Cash Flow -$25.50M -$38.29M -$143.65M -$23.12M -$53.91M
Gain/Loss from Continuing Operations – – $3.30M -$2.09B $790.46M

Discussion

No comments yet — be the first to weigh in on VOR.

Leave a comment

Scroll to Top